Iyer, G., Gao, X., Wei, A. Z., Park, I., Muro, K., O'Donnell, P. H., Garmezy, B., Galsky, M. D., Joshua, A. M., Patnaik, A., Lakhani, N. J., Gonzalez, A. F., Gauna, D. C., Philipovskiy, A., Call, J. A., Tripathi, A., Chang, A. E., Martin, E. A., Han, H., Powles, T. (2026). Initial results from NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4, in participants with advanced or metastatic urothelial carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4508